<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37098111</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1437-4331</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Clinical chemistry and laboratory medicine</Title><ISOAbbreviation>Clin Chem Lab Med</ISOAbbreviation></Journal><ArticleTitle>Addressing standardized definitions of post-COVID and long-COVID.</ArticleTitle><Pagination><StartPage>1361</StartPage><EndPage>1362</EndPage><MedlinePgn>1361-1362</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2023-0390</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lippi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9523-9054</Identifier><AffiliationInfo><Affiliation>IFCC SARS-CoV-2 Variants Working Group, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IFCC Task Force on COVID-19, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Brandon M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>IFCC SARS-CoV-2 Variants Working Group, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IFCC Task Force on COVID-19, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favresse</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IFCC SARS-CoV-2 Variants Working Group, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plebani</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0270-1711</Identifier><AffiliationInfo><Affiliation>IFCC SARS-CoV-2 Variants Working Group, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Chem Lab Med</MedlineTA><NlmUniqueID>9806306</NlmUniqueID><ISSNLinking>1434-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37098111</ArticleId><ArticleId IdType="doi">10.1515/cclm-2023-0390</ArticleId><ArticleId IdType="pii">cclm-2023-0390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mattiuzzi, C, Lippi, G. Timeline analysis of clinical severity of COVID-19 in the general population. Eur J Intern Med 2023;110:97&#x2013;8. https://doi.org/10.1016/j.ejim.2022.12.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.12.007</ArticleId></ArticleIdList></Reference><Reference><Citation>McVernon, J, Liberman, J. WHO keeps covid-19 a public health emergency of international concern. BMJ 2023;380:504. https://doi.org/10.1136/bmj.p504 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi, G, Sanchis-Gomar, F, Henry, BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med 2023;133:16402.</Citation></Reference><Reference><Citation>Pfaff, ER, Madlock-Brown, C, Baratta, JM, Bhatia, A, Davis, H, Girvin, A, N3C Consortium , RECOVER Consortium , et al.. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med 2023;21:58. https://doi.org/10.1186/s12916-023-02737-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Post COVID-19 condition (long COVID) ; 2022. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:&#x223c;:text=Definition,months%20with%20no%20other%20explanation [Accessed 14 Apr 2023].</Citation></Reference><Reference><Citation>Long COVID or Post-COVID Conditions . Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html [Accessed 14 Apr 2023].</Citation></Reference><Reference><Citation>Zhang, HG, Honerlaw, JP, Maripuri, M, Samayamuthu, MJ, Beaulieu-Jones, BR, Baig, HS, et al.. Potential pitfalls in the use of real-world data for studying long COVID. Nat Med 2023. https://doi.org/10.1038/s41591-023-02274-y [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02274-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello, A, Guarnieri, G, Braccioni, F, Lococo, S, Molena, B, Cecchetto, A, et al.. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med 2021;60:307&#x2013;16. https://doi.org/10.1515/cclm-2021-1021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>